Arronax Nantes > Expérimentation préclinique et recherche clinique > Nos Publications > 2020 > Publication 2020 10
Publication 2020 10
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease, Gouard S, Maurel C, Marionneau-Lambot S, Dansette D, Bailly C, Guérard F, et al, Cancers. 22 sept 2020;12(9):2721. https://doi.org/10.3390/cancers12092721